Comparison between Spandana Sphoorty Financial Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Spandana Sphoorty Financial Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025. Spandana Sphoorty Financial Rights Issue 2025 is listed on BSE, NSE while Valiant Laboratories Limited Rights Issue 2025 is listed on BSE, NSE.
| Spandana Sphoorty Financial Limited | Valiant Laboratories Limited | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | Amount for Rights Equity Shares Rs. 115.00/- shall be payable by the eligible shareholders at the time of application, and the balance Rs. 115.00/- in the 1st and Final call, as determined by the Board in consultation with the Rights Issue Committee | As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application. |
| Entitlement | 10 Rights Equity Share(s) for every 41 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. |
| Lead Managers |
The issue size of Spandana Sphoorty Financial Rights Issue 2025 rights issue is ₹400.00 Crores, whereas Valiant Laboratories Limited Rights Issue 2025 rights issue size is ₹81.47 Crores.
| Spandana Sphoorty Financial Limited | Valiant Laboratories Limited | |
|---|---|---|
| Issue Size | 1,73,91,304 shares | 1,08,62,500 shares |
| Issue Size (Amount) | ₹400.00 Crores | ₹81.47 Crores |
| Issue Price | ₹230 per share | ₹75 per share |
| Face Value | ₹5 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of Spandana Sphoorty Financial Rights Issue 2025 is Jul 24, 2025 while record date of Valiant Laboratories Limited Rights Issue 2025 is Jul 19, 2025.
| Spandana Sphoorty Financial Limited | Valiant Laboratories Limited | |
|---|---|---|
| Record Date | Jul 24, 2025 | Jul 19, 2025 |
| Credit of Rights Entitlements | Jul 25, 2025 | Jul 21, 2025 |
| Bid/Offer Opens On | Aug 01, 2025 | Jul 28, 2025 |
| Renunciation of Rights Entitlements | Aug 06, 2025 | Aug 05, 2025 |
| Bid/Offer Closes On | Aug 11, 2025 | Aug 08, 2025 |
| Deemed Date of Allotment | Aug 13, 2025 | Aug 11, 2025 |
| Credit Date | Aug 13, 2025 | Aug 12, 2025 |
| Listing Date | Aug 14, 2025 | Aug 13, 2025 |
Comparison of Spandana Sphoorty Financial Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Spandana Sphoorty Financial Limited | Valiant Laboratories Limited | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Spandana Sphoorty Financial Limited Financial Information (Restated Consolidated)Spandana Sphoorty Financial Limited's revenue decreased by 3% and profit after tax (PAT) dropped by 307% between the financial year ending with March 31, 2025 and March 31, 2024.
| Valiant Laboratories Limited Financial Information (Restated Consolidated)Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||
